SEPTEMBER ONCOLOGY CARTOONS BY DR KANHU CHARAN PATRO

SEPTEMBER ONCOLOGY CARTOONS BY DR KANHU CHARAN PATRO

1. DR KANHU CHARAN PATRO M.D, D.N.B[RT], MBA, FICRO, FAROI, PDCR, CEPC www.slideshare.net/search/slideshow?searchfrom=header&q=oncology+cartoons www.facebook.com/oncologycartoons/photos_albums 102 nd Volume/SEPTEMBER 2024 ONCOLOGY CRATOONS EDUCATIVE E-BOOK

2. 16 th AUG 2024/PAIN Management of chemo induced peripheral neuropathy https://www.uspharmacist.com/

3. 17 th AUG 2024 /PAIN NON-PHARMACOLOGICAL Management of chemo induced peripheral neuropathy https://www.uspharmacist.com/

4. 18 th AUG 2024 /PAIN MANAGEMENT ALGORITHM OF CHEMO INDUCED PERIPHERAL NEUROPATHY Knoerl et al. BMC Cancer (2021)

5. 19 th AUG 2024 /PAIN Neurohormonal mechanisms in cancer anorexia/cachexia CLINICAL PAIN MANAGEMENT

6. 20 th AUG 2024 /ADVANCED PATHY radiation ( PA rtial T umor irradiation targeting HY poxic segment) SlavisaTubin /seminars in radiation oncology/2024

7. 23 rd AUG 2024 /EYE Choroidal metastasis radiology https://eurorad.org/case/17876 Optical Coherence Tomography OCT comparison of dome-shaped retinal elevations and subretinal fluid in the right eye Axial T2- weighted image presents a subtly hyperintense choroidal lesion of the right eye . Post-contrast axial T1- a well-defined enhancing semilunar lesion at the right posterior globe. In addition, multiple nodular and ring-enhanced lesions were found in both cerebral hemispheres.

8. 24 th AUG 2024 /SRS RADIOBIOLOGY OF STREROTAXY CHANG W. SONG /IJROBP/2021

9. 28 th AUG 2024 / Lyphoma Characteristics of intraocular lymphoma Lynn Hassman /reviewofophthalmology.com/

10. 29 th AUG 2024 / Lyphoma Management of intraocular lymphoma Madalina La Rocca/cancers/2023

11. 30 th AUG 2024 /RCC Perioperative Nivolumab in RCC is there any role? PROSPER ECOG-ACRIN EA8143 Mohamad E Allaf / Lancet Oncology/2024

12. 31 st AUG 2024 /LUNG Resistance mechanisms to first-line osimertinib Egbert F Smi/FUTURE ONCOLOGY/2021

13. 1 st SEP 2024/LUNG Acquired resistance { MET } to Osimertinib – what next? Wi Long Wu/ Lancet Oncology/2024

14. 2 nd SEP 2024/OLIGO EUROPEAN GUIDELINES FOR OLIGO METS IGBT OF INNER ORGANS BOOK

15. 3 rd SEP 2024/METS Denosumab and osteoclast METASTSTIC BONE DISEASES BOOK

16. 4 th SEP 2024/BONE SOLITARY SPINE LESIONS AND CHARACTERSTICS METASTSTIC BONE DISEASES BOOK

17. INTEGRATION OF PALL CARE IN BONE METS 5 th SEP 2024/BONE METASTSTIC BONE DISEASES BOOK

18. Bone metabolism in normal & metastasis situation 6 th SEP 2024/BONE METASTSTIC BONE DISEASES BOOK

19. Radiosensitivity of various histologies –bone mets 7 th SEP 2024/BONE METASTSTIC BONE DISEASES BOOK

20. Metastatic castration prostate cancer and targets 8 th SEP 2024/BONE METASTSTIC BONE DISEASES BOOK

21. Key points about prostate brachytherapy 9 th SEP 2024/PROSTATE Nicholas G. Zaorsky / Nat Rev Urol/ 2017

22. Toxicities with HDR-BT, LDR-BT, and EBRT in ca prostate 10 th SEP 2024/PROSTATE Nicholas G. Zaorsky / Nat Rev Urol/ 2017

23. Case selection for prostate brachytherapy 11 th SEP 2024/PROSTATE Nicholas G. Zaorsky / Nat Rev Urol/ 2017

24. Prostate environment to select prostate brachytherapy 12 th SEP 2024/PROSTATE Nicholas G. Zaorsky / Nat Rev Urol/ 2017

25. Ideal candidates for salvage prostate brachytherapy 13 th SEP 2024/PROSTATE Nicholas G. Zaorsky / Nat Rev Urol/ 2017

26. Comparison of LDR-BT, HDR-BT, and EBRT 14 th SEP 2024/PROSTATE Nicholas G. Zaorsky / Nat Rev Urol/ 2017

27. September blood cancer awareness month 15 th SEP 2024/PUBLIC Google